Catalyst Wire Dossier Catalyst Wire Dossier

Alogliptin and pioglitazone

Alogliptin benzoate and pioglitazone hydrochloride · Padagis Israel Pharmaceuticals Ltd
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Alogliptin and pioglitazone, covering 2013-01-25 to 2024-06-28. Get the full timeline:

Most recent: FDA Approved: ALOGLIPTIN AND PIOGLITAZONE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)

See pricing